Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective

References

• Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119–125.
   PubMed Web of Science ®Google Scholar
• Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455–2461.
   PubMed Web of Science ®Google Scholar
• Tsang TS, Miyasaka Y, Barnes MD, et al. Epidemiological profile of atrial fibrillation: a contemporary perspective. Progress in Cardiovascular Diseases 2005; 48: 1–8.
   PubMed Web of Science ®Google Scholar
• Wolf PA, Benjamin EJ, Belanger AJ, et al. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. American Heart Journal 1996; 131: 790–795.
   PubMed Web of Science ®Google Scholar
• Furberg CD, Psaty BM, Manolio TA, et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). American Journal of Cardiology 1994; 74: 236–241.
   PubMed Web of Science ®Google Scholar
• Tsang TS, Petty GW, Barnes ME, et al. The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. Journal of the American College of Cardiology 2003; 42: 93–100.
   PubMed Web of Science ®Google Scholar
• Lakshminarayan K, Solid CA, Collins AJ, et al. Atrial fibrillation and stroke in the general Medicare population. A 10-year perspective (1992 to 2002). Stroke 2006; 37: 1969–1974.
   PubMed Web of Science ®Google Scholar
• Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Journal of the American Medical Association 2001; 285: 2370–2375.
   PubMed Web of Science ®Google Scholar
• Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. American Journal of Cardiology 1998; 82: 2N–9N.
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation 2004; 110: 1042–1046.
   PubMed Web of Science ®Google Scholar
• Khairallah F, Ezzedine R, Ganz LI, et al. Epidemiology and determinants of outcome of admissions for atrial fibrillation in the United States from 1996 to 2001. American Journal of Cardiology 2004; 94: 500–504.
   PubMed Web of Science ®Google Scholar
• Patel PJ, Keating RJ, Gersh BJ, et al. Outcome of patients with newly diagnosed atrial fibrillation at the Mayo clinic and residing in that area. American Journal of Cardiology 2004; 94: 1379–1382.
   Google Scholar
• Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. Journal of the American College of Cardiology 2004; 292: 2471–2477.
   Google Scholar
• Abusaada K, Sharma SB, Jaladi R, et al. Epidemiology and management of new-onset atrial fibrillation. American Journal of Managed Care 2004; 10: S50–S57.
   PubMedGoogle Scholar
• Johnson J, Napier KT. Atrial fibrillation. New theories, emerging treatments. Journal of the American Academy of Physician Assistants 2005; 18: 36–41.
   Google Scholar
• Snow V, Weiss KB, Le Fevre M, et al. Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Annals of Internal Medicine 2003; 139: 1009–1017.
   PubMed Web of Science ®Google Scholar
• van Walraven C, Hart RG, Wells GA, et al. A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Archives of Internal Medicine 2003; 163: 936–943.
   PubMedGoogle Scholar
• Greenlee RT, Vidaillet H. Recent progress in the epidemiology of atrial fibrillation. Current Opinion in Cardiology 2004; 20: 7–14.
   Web of Science ®Google Scholar
• Wu EQ, Birnbaum HG, Mareva M, et al. Economic burden and co-morbidities of atrial fibrillation in a privately insured population. Current Medical Research and Opinion 2005; 21: 1693–1699.
   PubMed Web of Science ®Google Scholar
• Stewart S, Murphy N, Walker A, et al. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 2004; 90: 286–292.
   PubMed Web of Science ®Google Scholar
• Le Heuzey JV, Paziaud O, Piot O, et al. Cost of care distribution in atrial fibrillation patients: The COCAF Study. American Heart Journal 2004; 147: 121–126.
   PubMed Web of Science ®Google Scholar
• Wattigney WA, Mensah GA, Croft JB, et al. Increasing trends in hospitalizations for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation 2003; 108: 711–716.
   PubMed Web of Science ®Google Scholar
• Abbott KC, Trespalacios FC, Taylor AJ, et al. Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality. BMC Nephrology 2003; 4: 1–10.
   PubMedGoogle Scholar
• Hravnak M, Hoffman LA, Saul MI, et al. Resource utilization related to atrial fibrillation after coronary artery bypass grafting. American Journal of Critical Care 2002; 11: 228.
   PubMedGoogle Scholar
• Lee WC, Christensen MC, Joshi AV, et al. Long-term cost of stroke subtypes among Medicare beneficiaries. Cerebrovascular Diseases 2007; 23: 57–65.
   PubMed Web of Science ®Google Scholar
• Lamas GA, Pashos CL, Normand ST, et al. Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. Circulation 1995; 91: 1063–1069.
   PubMedGoogle Scholar
• US Department of Labor. Bureau of Labor Statistics. Consumer Price Index. Available at: http://www.bls.gov/cpi/home.htm [accessed 22 March 2007].
   Google Scholar
• Duan N. Smearing estimate: a nonparametric retransformation method. Journal of the American Statistical Association 1983; 78: 605–610.
   Web of Science ®Google Scholar
• Wolf PA, Mitchell JB, Baker CS, et al. Impact of atrial fibrillation on mortality, stroke, and medical costs. Archives of Internal Medicine 1998; 158: 229–234.
   PubMed Web of Science ®Google Scholar
• Coyne KR, Paramore C, Grandy S, et al. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value in Health 2006; 9: 348–356.
   PubMed Web of Science ®Google Scholar
• Marshall DA, Levy AR, Vidaillet H, et al. Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Annals of Internal Medicine 2004; 141: 653–661.
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Essebag V, Zimetbaum P, et al. Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: The FRACTAL Registry. Journal of Cardiovascular Electrophysiology 2007; 18: 628–633.
   PubMed Web of Science ®Google Scholar
• Miller PSJ, Drummond MF, Langkilde LK, et al. Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation. European Heart Journal 2005; 7((Suppl C):)C41–C54.
   Google Scholar
• The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. New England Journal of Medicine 2002; 347: 1825–1833.
   PubMed Web of Science ®Google Scholar
• Miyasaka Y, Barnes ME, Gersh BJ, et al. Time trends of ischemic stroke incidence and mortality in patients diagnosed with first atrial fibrillation in 1980 to 2000. Report of a community-based study. Stroke 2005; 36: 2362–2366.
   Google Scholar
• Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke. Results from a population-based study. Stroke 2005; 36: 1115–1119.
   PubMed Web of Science ®Google Scholar